Posted inStock
Novo Nordisk Stock Gains as Wegovy HD Launch at $399 Targets US Obesity Market
Novo Nordisk (NVO) is drawing fresh investor attention after unveiling a higher-dose version of its blockbuster weight-loss drug in the United States, a move that comes as competition intensifies in…






